Ajanta Pharma

Ajanta Pharma is a specialty pharmaceutical formulation company engaged in the development, manufacture, and marketing of high-quality finished dosages. The company focuses on providing first-to-market products in specialty therapeutic segments, particularly in India and emerging markets. It operates a significant generics business in the United States, focusing on complex and niche products. The company maintains a strong R&D focus, with a dedicated center in Mumbai employing over 650 scientists. Their business model is diversified across branded generics in emerging markets (Asia and Africa), a branded specialty business in India, and a robust portfolio of ANDAs in the US market. They are known for their high margins and efficient capital allocation compared to industry peers.